Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Peripheral Arterial Disease
and you are
between 18 and 85
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

To compare the safety and effectiveness of dual anti-platelet therapy with cilostazol 100 mg twice daily and aspirin 100 mg daily versus monotherapy with aspirin 100 mg daily in patients undergoing peripheral angioplasty or stenting or both for the management of peripheral arterial disease.

Provided treatments

  • Drug: Cilostazol
  • Drug: Aspirin
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02770274. The sponsor of the trial is Attikon Hospital and it is looking for 200 volunteers for the current phase.
Official trial title:
Multi-center, Randomized Trial Comparing Dual Antiplatelet Therapy With CILOstazol Plus Aspirin Versus Aspirin Alone Following PERipheral Endovascular Procedures